Bill Doyle is executive chairman of Novocure, an Israeli company using an entirely new method to fight cancer: electric fields. Bill tells the story of the founder of Novocure, his unorthodox approach to problem-solving, and how he was able to commercialize a therapy that was considered voodoo science. He also discusses why the research grant process is broken and the FDA's challenge balancing progress with safety.

Bill has had a wide-ranging career in healthcare, spanning his time running medical device research at Johnson & Johnson to his role as chairman of Blink Health, a startup lowering prescription drug prices. Bill gets into what he thinks it takes to win as an entrepreneur, how he's learned about invention from Segway creator Dean Kamen, and why we're entering a golden age for medical innovation.     Full episode transcript on Medium.   This episode was produced by Allison Behringer.